Neurotrope's Phase 2 Drug To Treat Alzheimer's Doesn't Clear Threshold For Statistical Significance
Neurotrope Alzheimer's Phase 2 Trial Data Coming On Monday
Alzheimer's Pipeline In Focus At Oppenheimer Conference As Neurotrope's Trial Results Approach
After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?